Deep Genomics has secured $180m in Series C funding round to advance its artificial intelligence (AI)-discovered drug programmes for genetic diseases into the clinic.
US-based biopharmaceutical firm BridgeBio Pharma has raised $299.2m in a new financing round led by its existing investors KKR and Viking Global Investors.....